Clinical Trial Update: The Efficacy and Safety Profile of Capsaicin 8% Patch Versus 5% Lidocaine Patch in Males With Diabetic Neuropathy [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing capsaicin 8% patch to a 5% lidocaine patch in males with diabetic neuropathy completed, evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy

Drugs mentioned

• Capsaicin 8% patch (capsaicin)
• Lidocaine patch 5% (Lidocaine)

Snippet

Sponsor: Corporacion Parc Tauli | Conditions: Diabetic Nerve Problems, Diabetic Neuropathy | Phase 4 | Status: COMPLETED